Adjunctive Normobaric Hyperoxia With Endovascular Thrombectomy for Acute Stroke at 6 to 24 Hours: A Phase IIb Randomized Trial
Adjunktive normobare Hyperoxie mit endovaskulärer Thrombektomie bei akutem Schlaganfall 6 bis 24 Stunden nach Beginn: Phase-IIb-randomisierte Studie
Stroke · 2026-08 · 57 (8) · 2265-2275
DOI: 10.1161/strokeaha.125.055019 ↗Auf einen Blick
Bei 120 Patient:innen mit akutem ischämischem Schlaganfall war NBO plus EVT mit besserer früher neurologischer Besserung und kleinerem Infarktvolumen verbunden als EVT allein.
Fragestellung
Verbessert normobare Hyperoxie zusätzlich zur endovaskulären Thrombektomie bei akutem ischämischem Schlaganfall 6 bis 24 Stunden nach Beginn Sicherheit und frühe Wirksamkeit?
Methode
Phase-IIb, randomisierte, beobachterverblindete, kontrollierte Studie an 2 Schlaganfallzentren in China; 1:1 zu EVT+NBO oder EVT allein; Intention-to-treat-Analyse.
Ergebnisse
120 Patient:innen, je 60 pro Gruppe. Frühe neurologische Besserung: 35 % vs. 19 %; adjustierte OR 2,86 (95 %-KI 1,12–7,45). Infarktvolumen: 20,5 vs. 32,3 mL; P =0,001. mRS 90 Tage nicht signifikant.
Schlussfolgerung der Autor:innen
Bei akutem ischämischem Schlaganfall 6 bis 24 Stunden nach Beginn war adjunktive NBO mit EVT sicher und verbesserte frühe neurologische Ergebnisse und das Infarktvolumen; weitere Prüfung in größeren Studien wird unterstützt.
Kernaussagen
- Frühe neurologische Besserung häufiger mit EVT+NBO als mit EVT allein
- Infarktvolumen 24 bis 48 Stunden kleiner unter EVT+NBO
- Keine Unterschiede bei Mortalität oder symptomatischer intrakranieller Blutung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Stroke, 2026-08. Verfasst von Weili Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cerebrovascular Diseases Research Institute (W.L., W.H., X.J.), Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Thrombectomy, Endovascular Procedures, Ischemic Stroke, Hyperoxia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Normobaric hyperoxia (NBO) is a simple neuroprotective strategy that may augment endovascular thrombectomy (EVT) in acute ischemic stroke. We evaluated the safety and preliminary efficacy of NBO plus EVT in patients with large-vessel occlusion presenting 6 to 24 hours after onset. METHODS: In this phase IIb, randomized, assessor-blinded, controlled trial conducted at 2 academic comprehensive stroke centers in China, patients aged ≥18 years with anterior circulation large-vessel occlusion presenting 6 to 24 hours after acute ischemic stroke onset were assigned 1:1 to EVT+NBO or EVT alone. The NBO group received 100% oxygen via a face mask at 10 L/min for 4 hours, starting before recanalization. The primary end point was early neurological improvement (≥30% reduction in the National Institutes of Health Stroke Scale score at 24 hours). Primary analyses used adjusted regression models controlling for prespecified prognostic covariates. Secondary end points included infarct volume at 24 to 48 hours and the modified Rankin Scale score at 90 days. Safety outcomes were mortality, intracranial hemorrhage, and symptomatic intracranial hemorrhage. Analyses followed the intention-to-treat principle. Early neurological improvement was analyzed using an adjusted binomial regression model, and the 90-day modified Rankin Scale shift was analyzed using an adjusted ordinal logistic regression model, controlling for age, sex, intravenous thrombolysis, and occlusion site. RESULTS: Between October 2021 and October 2023, 324 patients were screened, and 120 were randomly assigned to NBO+EVT or EVT alone (60 patients per group; intention-to-treat population). The median baseline National Institutes of Health Stroke Scale score was 12 (interquartile range [IQR], 8–15) in the NBO+EVT group and 12 (IQR, 9–16) in the EVT-alone group. The median time from stroke onset to randomization was 10.0 hours (IQR, 7.0–14.4) and 9.9 hours (IQR, 8.4–14.8), respectively. The EVT+NBO group demonstrated a significantly higher rate of early neurological improvement compared with EVT alone (35% versus 19%; adjusted odds ratio, 2.86 [95% CI, 1.12–7.45]). The median infarct volume at 24 to 48 hours was significantly smaller in the EVT+NBO group (20.5 [IQR, 13.6–31.8] mL versus 32.3 [IQR, 22.7–44.5] mL; P =0.001). At 90 days, the modified Rankin Scale distribution numerically favored NBO+EVT but was not statistically significant (median modified Rankin Scale, 2 [IQR, 1–3] versus 3 [IQR, 1–4]; adjusted common odds ratio, 1.52 [95% CI, 0.87–2.63]). Mortality, symptomatic intracranial hemorrhage, early neurological deterioration, and recurrent stroke did not differ between groups. CONCLUSIONS: In patients with acute ischemic stroke treated 6 to 24 hours after onset, adjunctive NBO with EVT was safe and improved early neurological outcomes and infarct volume, supporting further evaluation in larger trials. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05128422.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cerebrovascular Diseases Research Institute (W.L., W.H., X.J.), Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Neurology, Cerebrovascular Diseases Research Institute, Weifang People's Hospital, Shandong Second Medical University, China (W.L.).
- Department of Neurology (W.H., Q.M.), Xuanwu Hospital, Capital Medical University, Beijing, China.
- Huanhu Hospital Affiliated to Tianjin Medical University, China (S.W., S.L.).
- Department of Neurosurgery, Tianjin Huanhu Hospital, China (S.W., S.L.).
- Department of Neurology, Jiujiang University Affiliated Hospital, China (Z.C.).
ORCID-Profile: Weili Li, Wenbo Hu, Sifei Wang, Jiayue Ding, Qingfeng Ma, Ke Jian Liu, Wuwei Feng, Shuling Liu, Xunming Ji
Zitieren
APA
Li, W., Hu, W., Wang, S., Chen, Z., Ding, J., Ma, Q., Liu, K. J., Feng, W., Liu, S., & Ji, X. (2026). Adjunctive Normobaric Hyperoxia With Endovascular Thrombectomy for Acute Stroke at 6 to 24 Hours: A Phase IIb Randomized Trial. Stroke, 57(8), 2265-2275. https://doi.org/10.1161/strokeaha.125.055019
Vancouver
Li W, Hu W, Wang S, Chen Z, Ding J, Ma Q, et al. Adjunctive Normobaric Hyperoxia With Endovascular Thrombectomy for Acute Stroke at 6 to 24 Hours: A Phase IIb Randomized Trial. Stroke. 2026;57(8):2265-2275. doi:10.1161/strokeaha.125.055019
BibTeX
@article{Li2026,
author = {Li, Weili and Hu, Wenbo and Wang, Sifei and Chen, Zhiying and Ding, Jiayue and Ma, Qingfeng and Liu, Ke Jian and Feng, Wuwei and Liu, Shuling and Ji, Xunming},
title = {Adjunctive Normobaric Hyperoxia With Endovascular Thrombectomy for Acute Stroke at 6 to 24 Hours: A Phase IIb Randomized Trial},
journal = {Stroke},
year = {2026},
volume = {57},
number = {8},
pages = {2265--2275},
doi = {10.1161/strokeaha.125.055019}
}
EUVIMED